Fonte: American Journal of Hematology. Unidade: FMRP
Assuntos: ANTINEOPLÁSICOS, TERAPIA COMBINADA, MIELOMA MÚLTIPLO, MODELOS DE RISCOS PROPORCIONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIOLINO, Angelo et al. Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma. American Journal of Hematology, v. 87, n. 10, p. 948-952, 2012Tradução . . Disponível em: https://doi.org/10.1002/ajh.23274. Acesso em: 14 nov. 2024.APA
Maiolino, A., Hungria, V. T. M., Garnica, M., Duarte, G. O., Oliveira, L. C. O. de, Mercante, D. R., et al. (2012). Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma. American Journal of Hematology, 87( 10), 948-952. doi:10.1002/ajh.23274NLM
Maiolino A, Hungria VTM, Garnica M, Duarte GO, Oliveira LCO de, Mercante DR, Miranda EC, Quero AA, Peres ALM, Barros JC, Tanaka P, Magalhães RP, Rego EM, Lorand-Metze I, Lima CSP, Renault IZ, Braggio E, Chiattone C, Nucci M, Souza CA de. Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma [Internet]. American Journal of Hematology. 2012 ; 87( 10): 948-952.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/ajh.23274Vancouver
Maiolino A, Hungria VTM, Garnica M, Duarte GO, Oliveira LCO de, Mercante DR, Miranda EC, Quero AA, Peres ALM, Barros JC, Tanaka P, Magalhães RP, Rego EM, Lorand-Metze I, Lima CSP, Renault IZ, Braggio E, Chiattone C, Nucci M, Souza CA de. Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma [Internet]. American Journal of Hematology. 2012 ; 87( 10): 948-952.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/ajh.23274
